Aspirin may prevent heart attacks, but probably not cancer

Article

While low-dose aspirin may help prevent heart disease, a randomized, placebo-controlled study of almost 40,000 women finds that alternate day use of 100 mg aspirin for an average of 10 years does not lower the risk of total, breast, or colorectal cancer.

While low-dose aspirin may help prevent heart disease, a randomized, placebo-controlled study of almost 40,000 women finds that alternate day use of 100 mg aspirin for an average of 10 years does not lower the risk of total, breast, or colorectal cancer.

The study, which is the longest of any trial on this matter to be completed to date and which is part of the Women's Health Study, did show a trend toward reduction in the risk of lung cancer that was significant for lung cancer deaths, but the findings require confirmation.

Whether higher doses of aspirin confer protective benefits, as some previous studies have indicated, cannot be ruled out.

Recent Videos
Baher Mankabady, MD, highlights safety of buprenorphine against OUD in pregnancy | Image Credit: linkedin.com.
Devon Ramaeker, MD
Elizabeth Gandee, APRN-CNP, highlights gaps in women's menopause knowledge | Image Credit: wexnermedical.osu.edu
Doula highlights how postpartum care is failing new mothers | Image Credit: linkedin.com
Nicky Herrick MD; and Anushree Agarwal, MD, MBBS, highlight their study on cardiac arrhythmias in pregnancy | Image Credit: © Igor Borodin - stock.adobe.com.
Lisa Becht, MD, FACOG, sheds light on fertility awareness | Image Credit: havingbabies.com.
First US national HPV conference highlights advances in cancer prevention | Image Credit: uchealth.com.
Mitchell Creinin, MD, reports estetrol pill eases menstrual symptoms | Image Credit: health.ucdavis.edu
1 expert is featured in this series.
Susanna Mitro, PhD, reveals ethnic disparities in uterine fibroid diagnosis | Image Credit: divisionofresearch.kaiserpermanente.org.
Related Content
© 2025 MJH Life Sciences

All rights reserved.